← Open Payments lookup

DAVID MILLER: Open Payments

NPI 1013916972 · LOUISVILLE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,073 in 48 payments from 11 companies in 2025. Trend: 2023 $921 · 2024 $979 · 2025 $1,073

Food & beverage: $1,073
CompanyPaymentsAmount
ABBVIE INC.18$297
Bausch Health US, LLC11$223
E.R. Squibb & Sons, L.L.C.7$176
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$127
Axsome Therapeutics, Inc.2$60
Alkermes, Inc.2$57
Otsuka America Pharmaceutical, Inc.2$40
Neurocrine BioSciences, Inc.1$26
Janssen Pharmaceuticals, Inc1$25
Collegium Pharmaceutical, Inc.1$22

Products named: VRAYLAR, COBENFY, APLENZIN, CAPLYTA, Auvelity, WELLBUTRIN, LYBALVI, REXULTI.

Industry payments across CO — which companies pay providers there.